BEAM
Beam Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$29.66
+0.68%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 64.80x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.87x
- Price / sales
- 19.63x
- Price / cash flow
- -8.52x
Enterprise value
- Enterprise value
- $2.2B
- EV / sales
- 13.83x
- EV / EBITDA
- -35.79x
- EV / EBIT
- -5.71x
- Market cap
- $3.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026